Skip to content

To compare the effect of two drugs for General Anesthesia in pediatric patients

A comparison of atracurium and cisatracurium with respect to laryngeal relaxation and hemodynamic stability in pediatric patients for general anaesthesia - randomized double blind controlled study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/08/035495
Enrollment
104
Registered
2021-08-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Administration of cisatracurium: Cisatracurium 0.1mg/kg IV for intubation and thereafter 0.02 mg/kg as needed for surgical relaxation. Control Intervention1: Administration of atracuriu

Sponsors

Dr Arshad N N
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Age : 3 to 12 years 2) ASA Patients: I andII 3) Gender : Male and Female 4) Surgery: Elective surgery under GA, expected duration > 30 minutes

Exclusion criteria

Exclusion criteria: 1) Parents not willing for consent 2) Patients having known allergy to muscle relaxants 3) Patients with airway problems suggestive of difficult intubation 4) More than two attempts of laryngoscopy 5) Patients with neuromuscular diseases like myasthenia and myopathies 6) Patients receiving medications that interfere with neuromuscular blockade like phenytoin, valproate,carbamazepine, ethosuximide,lamotrigine,leveteracetam 7) Patients with disorder of cardiovascular, respiratory hepatic or renal systems

Design outcomes

Primary

MeasureTime frame
1. To compare the efficacy of atracurium and cisatracurium with respect to intubating conditions and hemodynamic stability.Timepoint: 180 minutes

Secondary

MeasureTime frame
1 To assess sideeffects of atracurium and cisatracuriumTimepoint: 180 minutes

Countries

India

Contacts

Public ContactDr NK Agrawal

All India Institute of Medical Sciences

nkagrawal1963@gmail.com9373103294

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026